Ticker name:ABTABBOTT LABORATORIES

Country: US-Sector: Healthcare, Industry: Medical - Devices

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Market Cap 200B

Last close 115.51$

Key metrics

Largest 20 companies In Medical - Devices

# PositionTickerCompany NameMarket CapLast PriceAction
1ABTABBOTT LABORATORIES200B115.51$
2ISRGINTUITIVE SURGICAL INC167B482.1$
3MDTMedtronic plc134B104.96$
4SYKSTRYKER CORP129B339.65$
5BSXBOSTON SCIENTIFIC CORP66B45.82$
6EWEdwards Lifesciences Corp57B99.37$
7RMDRESMED INC34B240.51$
8DXCMDEXCOM INC33B88.48$
9ZBHZIMMER BIOMET HOLDINGS, INC.21B110.15$
10GKOSGLAUKOS Corp15B246.7$
11SNNSMITH & NEPHEW PLC14B32.46$
12PENPenumbra Inc13B322.45$
13ALGNALIGN TECHNOLOGY INC12B164.9$
14GMEDGLOBUS MEDICAL INC12B87.1$
15PODDINSULET CORP11B165.02$
16BIOBIO-RAD LABORATORIES, INC.10B379.99$
17BRKRBRUKER CORP9.7B63.79$
18LIVNLivaNova PLC5.2B94.19$
19IRTCiRhythm Holdings, Inc.4.4B134$
20ITGRInteger Holdings Corp4.3B126.64$